MAVS Antibodies

Santa Cruz Biotechnology features a diverse variety of MAVS Antibodies for research focused on understanding mitochondrial antiviral signaling. MAVS Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MAVS, or mitochondrial antiviral signaling protein, plays a crucial role in the innate immune response by mediating the signaling pathways that activate antiviral defenses. MAVS is essential for the detection of viral RNA and the subsequent activation of interferon production, making it a key player in the host's defense against viral infections. Understanding the function and regulation of MAVS continues to be an active area of research in viral immunology. MAVS research has revealed significant insights into cellular defense mechanisms and antiviral responses. Ongoing studies of MAVS signaling pathways have enhanced our knowledge of host-pathogen interactions. Current investigations are uncovering new aspects of MAVS-mediated immune responses. Santa Cruz Biotechnology monoclonal antibodies for MAVS support researchers worldwide in advancing our understanding of antiviral immunity.